Beranda › Hidradenitis Suppurativa › Texas
Uji klinis Hidradenitis Suppurativa di Texas
8 studi untuk Hidradenitis Suppurativa mencari peserta di lokasi di Texas.
Kota di Texas
Teks studi resmi (Bahasa Inggris)
An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS
- Center for Clinical Studies-Lee, Webster
Menerima pesertaFase 3
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07665437ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis Suppurativa
- Oruka Therapeutics Investigative Site, Dallas
- Oruka Therapeutics Investigative Site, Missouri City
- Oruka Therapeutics Investigative Site, San Antonio
Menerima pesertaFase 2
Usia 18 hingga 79 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT07783542A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
- Elligo Health Research/The Woodlands Dermatology Associates- Site Number : 8400020, The Woodlands
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07225569Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
- Investigative Site US021, Bellaire
- Investigative Site US078, Dallas
- Investigative Site US010, Dallas
- dan 3 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT06855498Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa
- UT Southwestern Medical Center, Department of Dermatology- Site Number : 8400022, Dallas
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT07170917Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
- Bellaire Dermatology Associates Bda, Bellaire
- Texas Dermatology Research Center, Dallas
- 3A Research Llc West Location, El Paso
Menerima pesertaFase 2
Usia 12 hingga 17 · Semua jenis kelamin · Diperbarui 6 Agu 2026 · NCT07213973A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic
- The University of Texas MD Anderson Cancer Center, Houston
Menerima pesertaStudi observasional
Usia 18 hingga 71 · Semua jenis kelamin · Diperbarui 16 Apr 2026 · NCT07123038A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
- Arlington Research Center, Inc., Arlington
- Texas Dermatology Research Center, Dallas
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Mar 2026 · NCT07244263Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.